Pnc Financial Services Group, Inc. Pmv Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 62,134 shares of PMVP stock, worth $66,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,134
Previous 69,113
10.1%
Holding current value
$66,483
Previous $104,000
35.58%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PMVP
# of Institutions
63Shares Held
40.2MCall Options Held
1.8KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$6.93 Million0.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.75MShares$4.01 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$4 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$3.54 Million0.07% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.3MShares$3.53 Million0.29% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $48.8M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...